TITLE

Financing Health Care for Persons with HIV Infection: Guidelines for State Action

AUTHOR(S)
Fox, Daniel M.
PUB. DATE
March 1990
SOURCE
American Journal of Law & Medicine;1990, Vol. 16 Issue 1/2, p223
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Promises of confidentiality of HIV-related medical records and protection from discrimination based on HIV seropositivity are two of the legislative inducements state governments have offered to encourage voluntary HIV testing. Yet neither can be granted without impact on others whose interests range from those of a lover to those of an insurer. Politics as well as practicalities prevent the absolute protection of records from unauthorized disclosure and of individuals from discrimination. This article details the already enacted statutory compromises that have been made to resolve the conflicts of these competing interests and closely examines the myriad fine decisions made in reaching those legislative decisions.
ACCESSION #
6333604

 

Related Articles

  • Option A or B the best route?  // PharmacoEconomics & Outcomes News;8/20/2011, Issue 635, p5 

    The article discusses a study which examined the impact on costs and mother-to-child transmission (MTCT) of human immunodeficiency virus (HIV) for two treatment options in Tanzania.

  • Cost of treating HIV remains high; Louisiana feels the pain. Daugherty, Christi // New Orleans CityBusiness (1994 to 2008);12/14/98, Vol. 19 Issue 24, p25 

    Reports on the rise of drug therapy costs for HIV infection in Louisiana. Insurance coverage of patients with HIV; Average expenses of patients with HIV or AIDS; Reasons for the increase of HIV drug therapy costs; Effects of drug therapy to people with HIV.

  • The Costs of HIV Infections. Harris, Carl M.; Rattner, Edward // JAMA: Journal of the American Medical Association;2/23/90, Vol. 263 Issue 8, p1067 

    Comments on an article, previously published in the 'Journal of American Medical Association,' concerning the costs of HIV infection treatment in the United States.

  • Little money incentivises HIV screening in Tanzania.  // PharmacoEconomics & Outcomes News;Aug2015, Vol. 735 Issue 1, p20 

    The article reviews the report "Would You Test for 5000 Shillings? HIV Risk and Willingness to Accept HIV Testing in Tanzania," by J. Ostermann et al., published in the August 19, 2015 issue of the "Health Economics Review" journal, about human immunodeficiency virus (HIV) testing in Tanzania.

  • Building African AIDS Care from the Ground Up.  // Annals of Internal Medicine;7/15/2003, Vol. 139 Issue 2, p157 

    The epicenter of AIDS activity in the early 1980s was San Francisco General Hospital, where Merle Sande, MD, was chief of medicine. Within the next decade, physicians in the United States learned how to treat HIV infection and AIDS as pharmaceutical companies launched drugs that controlled the...

  • Budget Impact of Medicaid Section 1115 Demonstrations for Early HIV Treatment. Schackman, Bruce R.; Freedberg, Kenneth A.; Goldie, Sue J.; Weinstein, Milton C.; Swartz, Katherine // Health Care Financing Review;Summer2005, Vol. 26 Issue 4, p67 

    A state-transition model of HIV disease was used to project the costs to Medicaid, Medicare, and AIDS Drug Assistance Programs of proposed Section 1115 Medicaid demonstration projects for the early treatment of HIV-infected patients in Georgia and Massachusetts. Neither demonstration project was...

  • Coping with the cost burdens of illness: Combining qualitative and quantitative methods in longitudinal, household research. Goudge, Jane; Gumede, Tebogo; Gilson, Lucy; Russell, Steve; Tollman, Stephen M.; Mills, Anne // Scandinavian Journal of Public Health;May2007 Supplement 69, Vol. 35 Issue s69, p181 

    Over the last 10-15 years, poor African households have had to cope with the burden of increased levels of chronic illness such as HIV/AIDS. How do these households cope with the cost burdens of ill health and healthcare, and has this burden further impoverished them? What policy responses might...

  • Higher drug costs lowers the overall costs for inner-city AIDS program, study finds.  // Formulary;Feb99, Vol. 34 Issue 2, p165 

    Focuses on a Baltimore, Maryland HIV treatment study which found that three-drug regimens containing a protease inhibitor and one- and two-drug regimens without a protease inhibitor have similar overall costs. Charges for acute and chronic inpatient care; Outpatient care; Drug prescriptions;...

  • State AIDS Drug Assistance Programs Continue to Face Difficult Funding Challenges; 11 States Close Enrollment, 9 Have Waiting Lists to Receive HIV Drugs; Wide Variation in Access to HIV...  // Ascribe Newswire: Medicine;5/20/2004, p165 

    Despite a 9 percent increase in the overall AIDS Drug Assistance Programs (ADAPs) budget in the U.S. between fiscal year 2002 and 2003, an increasing number of people living longer with HIV/AIDS, the rising costs of HIV medications, and continuing fiscal pressures at the Federal and state levels...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics